Maze Therapeutics
Develops genetic-based precision medicines for renal and cardiovascular diseases.
Company facts
- Founded
- 2017
- Employees
- 148
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: MAZE
Develops genetic-based precision medicines for renal and cardiovascular diseases.
Company facts